Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1983 Apr;50:139–148. doi: 10.1289/ehp.8350139

Alternative hypotheses for the role of promotion in chemical carcinogenesis.

V R Potter
PMCID: PMC1569220  PMID: 6223811

Abstract

A new protocol for carcinogenesis in rat liver is described in order that confirmatory experiments might be undertaken concurrently. The basic protocol, designated IPI (initiator + promoter + initiator), is presented in several alternative forms, including the possible use of X-irradiation as the initiator. The rationale is discussed in terms of the two-hit somatic mutation theory of Armitage and Doll, with an initial hit produced by the first dose of initiator and expansion of single cells to sizable clones by promotion thereby increasing the probability of a second hit by the second dose of initiator. The question of relevant mutations was taken up and it was proposed that genes for chalones (C) and for chalone receptors (R) are logical targets for consideration in a two-mutation sequence. Alternative hypotheses pertaining to promoter action were described in terms of possible mechanisms by which nonelectrophilic promoters might simulate a second mutation by increasing or decreasing the levels of a nonchromosomal replicating particle in target cells.

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMITAGE P., DOLL R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer. 1957 Jun;11(2):161–169. doi: 10.1038/bjc.1957.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BULLOUGH W. S. The control of mitotic activity in adult mammalian tissues. Biol Rev Camb Philos Soc. 1962 Aug;37:307–342. doi: 10.1111/j.1469-185x.1962.tb01615.x. [DOI] [PubMed] [Google Scholar]
  3. Barnes D., Sato G. Serum-free cell culture: a unifying approach. Cell. 1980 Dec;22(3):649–655. doi: 10.1016/0092-8674(80)90540-1. [DOI] [PubMed] [Google Scholar]
  4. Becker F. F. Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide. Cancer Res. 1975 Jul;35(7):1734–1736. [PubMed] [Google Scholar]
  5. Brown M. S., Goldstein J. L. New directions in human biochemical genetics: understanding the manifestations of receptor deficiency states. Prog Med Genet. 1976;1:103–119. [PubMed] [Google Scholar]
  6. Campbell H. A., Pitot H. C., Potter V. R., Laishes B. A. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res. 1982 Feb;42(2):465–472. [PubMed] [Google Scholar]
  7. Carpenter G., Cohen S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216. doi: 10.1146/annurev.bi.48.070179.001205. [DOI] [PubMed] [Google Scholar]
  8. Cole L. J., Nowell P. C. Radiation carcinogenesis: the sequence of events. Science. 1965 Dec 31;150(3705):1782–1786. doi: 10.1126/science.150.3705.1782. [DOI] [PubMed] [Google Scholar]
  9. Cuatrecasas P., Hollenberg M. D. Membrane receptors and hormone action. Adv Protein Chem. 1976;30:251–451. doi: 10.1016/s0065-3233(08)60481-7. [DOI] [PubMed] [Google Scholar]
  10. Gayda D. P., Pariza M. W. Activation of aflatoxin B1 by primary cultures of adult rat hepatocytes: effects of hepatocyte density. Chem Biol Interact. 1981 Jun;35(3):255–265. doi: 10.1016/0009-2797(81)90001-6. [DOI] [PubMed] [Google Scholar]
  11. Goldstein J. L., Brown M. S., Stone N. J. Genetics of the LDL receptor: evidence that the mutations affecting binding and internalization are allelic. Cell. 1977 Nov;12(3):629–641. doi: 10.1016/0092-8674(77)90263-x. [DOI] [PubMed] [Google Scholar]
  12. Holley R. W., Böhlen P., Fava R., Baldwin J. H., Kleeman G., Armour R. Purification of kidney epithelial cell growth inhibitors. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5989–5992. doi: 10.1073/pnas.77.10.5989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. King A. C., Cuatrecasas P. Peptide hormone-induced receptor mobility, aggregation, and internalization. N Engl J Med. 1981 Jul 9;305(2):77–88. doi: 10.1056/NEJM198107093050206. [DOI] [PubMed] [Google Scholar]
  14. Leffert H. L., Koch K. S. Ionic events at the membrane initiate rat liver regeneration. Ann N Y Acad Sci. 1980;339:201–215. doi: 10.1111/j.1749-6632.1980.tb15979.x. [DOI] [PubMed] [Google Scholar]
  15. Leffert H. L., Paul D. Studies on primary cultures of differentiated fetal liver cells. J Cell Biol. 1972 Mar;52(3):559–568. doi: 10.1083/jcb.52.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leffert H. L., Weinstein D. B. Growth control of differentiated fetal rat hepatocytes in primary monolayer culture. IX. Specific inhibition of DNA synthesis initiation by very low density lipoprotein and possible significance to the problem of liver regeneration. J Cell Biol. 1976 Jul;70(1):20–32. doi: 10.1083/jcb.70.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McMahon J. B., Farrelly J. G., Iype P. T. Purification and properties of a rat liver protein that specifically inhibits the proliferation of nonmalignant epithelial cells from rat liver. Proc Natl Acad Sci U S A. 1982 Jan;79(2):456–460. doi: 10.1073/pnas.79.2.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McMahon J. B., Iype P. T. Specific inhibition of proliferation of nonmalignant rat hepatic cells by a factor from rat liver. Cancer Res. 1980 Apr;40(4):1249–1254. [PubMed] [Google Scholar]
  19. Miller E. C., Miller J. A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer. 1981 May 15;47(10):2327–2345. doi: 10.1002/1097-0142(19810515)47:10<2327::aid-cncr2820471003>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  20. Moolgavkar S. H., Knudson A. G., Jr Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 1981 Jun;66(6):1037–1052. doi: 10.1093/jnci/66.6.1037. [DOI] [PubMed] [Google Scholar]
  21. Moses A. C., Nissley S. P., Short P. A., Rechler M. M., White R. M., Knight A. B., Higa O. Z. Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3649–3653. doi: 10.1073/pnas.77.6.3649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Murray A. W., Fitzgerald D. J. Tumor promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cells. Biochem Biophys Res Commun. 1979 Nov 28;91(2):395–401. doi: 10.1016/0006-291x(79)91535-3. [DOI] [PubMed] [Google Scholar]
  23. Newmark P. Tyrosine phosphorylation and oncogenes. Nature. 1981 Jul 2;292(5818):15–16. doi: 10.1038/292015a0. [DOI] [PubMed] [Google Scholar]
  24. Onda H. A new hypothesis on mitotic control mechanism in eukaryotic cells: cell-specific mitosis-inhibiting protein excretion hypothesis. J Theor Biol. 1979 Apr 7;77(3):367–377. doi: 10.1016/0022-5193(79)90362-x. [DOI] [PubMed] [Google Scholar]
  25. POTTER V. R., PRICE J. M. Studies on the intracellular composition of livers from rats fed various aminoazo dyes; effects on succinoxidase and oxalacetic acid oxidase. Cancer Res. 1950 Jan;10(1):28–35. [PubMed] [Google Scholar]
  26. Paul D., Leffert H., Sato G., Holley R. W. Stimulation of DNA and protein synthesis in fetal-rat liver cells by serum from partially hepatectomized rats. Proc Natl Acad Sci U S A. 1972 Feb;69(2):374–377. doi: 10.1073/pnas.69.2.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Peraino C., Fry R. J., Staffeldt E., Kisieleski W. E. Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res. 1973 Nov;33(11):2701–2705. [PubMed] [Google Scholar]
  28. Peraino C., Staffeldt E. F., Ludeman V. A. Early appearance of histochemically altered hepatocyte foci and liver tumors in female rats treated with carcinogens one day after birth. Carcinogenesis. 1981;2(5):463–465. doi: 10.1093/carcin/2.5.463. [DOI] [PubMed] [Google Scholar]
  29. Pitot H. C., Goldsworthy T., Campbell H. A., Poland A. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 1980 Oct;40(10):3616–3620. [PubMed] [Google Scholar]
  30. Platt J. R. Strong Inference: Certain systematic methods of scientific thinking may produce much more rapid progress than others. Science. 1964 Oct 16;146(3642):347–353. doi: 10.1126/science.146.3642.347. [DOI] [PubMed] [Google Scholar]
  31. Potter V. R. A new protocol and its rationale for the study of initiation and promotion of carcinogenesis in rat liver. Carcinogenesis. 1981;2(12):1375–1379. doi: 10.1093/carcin/2.12.1375. [DOI] [PubMed] [Google Scholar]
  32. Potter V. R. Hormonal induction of enzyme functions, cyclic AMP levels and AIB transport in Morris hepatomas and in normal liver systems. Adv Exp Med Biol. 1977 May 22;92:59–87. doi: 10.1007/978-1-4615-8852-8_4. [DOI] [PubMed] [Google Scholar]
  33. Potter V. R. Initiation and promotion in cancer formation: the importance of studies on intercellular communication. Yale J Biol Med. 1980 Sep-Oct;53(5):367–384. [PMC free article] [PubMed] [Google Scholar]
  34. Potter V. R. The present status of the blocked ontogeny hypothesis of neoplasia: the thalassemia connection. Oncodev Biol Med. 1981;2(4):243–266. [PubMed] [Google Scholar]
  35. Preer J. R. Some Properties of a Genetic Cytoplasmic Factor in Paramecium. Proc Natl Acad Sci U S A. 1946 Sep;32(9):247–253. doi: 10.1073/pnas.32.9.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sachs L. Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6152–6156. doi: 10.1073/pnas.77.10.6152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schaeffer W. I. The long-term culture of a diploid rat hepatocyte cell strain. Ann N Y Acad Sci. 1980;349:165–182. doi: 10.1111/j.1749-6632.1980.tb29524.x. [DOI] [PubMed] [Google Scholar]
  38. Sporn M. B., Todaro G. J. Autocrine secretion and malignant transformation of cells. N Engl J Med. 1980 Oct 9;303(15):878–880. doi: 10.1056/NEJM198010093031511. [DOI] [PubMed] [Google Scholar]
  39. Trosko J. E., Chang C. C. An integrative hypothesis linking cancer, diabetes and atherosclerosis: the role of mutations and epigenetic changes. Med Hypotheses. 1980 May;6(5):455–468. doi: 10.1016/0306-9877(80)90098-5. [DOI] [PubMed] [Google Scholar]
  40. Tsuda H., Lee G., Farber E. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res. 1980 Apr;40(4):1157–1164. [PubMed] [Google Scholar]
  41. Umeda M., Noda K., Ono T. Inhibition of metabolic cooperation in Chinese hamster cells by various chemical including tumor promoters. Gan. 1980 Oct;71(5):614–620. [PubMed] [Google Scholar]
  42. Varshavsky A. On the possibility of metabolic control of replicon "misfiring": relationship to emergence of malignant phenotypes in mammalian cell lineages. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3673–3677. doi: 10.1073/pnas.78.6.3673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Varshavsky A. Phorbol ester dramatically increases incidence of methotrexate-resistant mouse cells: possible mechanisms and relevance to tumor promotion. Cell. 1981 Aug;25(2):561–572. doi: 10.1016/0092-8674(81)90074-x. [DOI] [PubMed] [Google Scholar]
  44. Voss P. G., Steck P. A., Calamia J. C., Wang J. L. Growth control in cultured 3T3 fibroblasts. III. Binding interactions of a growth inhibitory activity with target cells. Exp Cell Res. 1982 Apr;138(2):397–407. doi: 10.1016/0014-4827(82)90188-4. [DOI] [PubMed] [Google Scholar]
  45. Williams G. M. Classification of genotoxic and epigenetic hepatocarcinogens using liver culture assays. Ann N Y Acad Sci. 1980;349:273–282. doi: 10.1111/j.1749-6632.1980.tb29532.x. [DOI] [PubMed] [Google Scholar]
  46. Yotti L. P., Chang C. C., Trosko J. E. Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science. 1979 Nov 30;206(4422):1089–1091. doi: 10.1126/science.493994. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES